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Abstract
IL-15 cDNA of Tibetan pig was firstly cloned from its activated lymphocytes, and then was sub-cloned into VR1020 to construct
recombinant VRTIL-15 plasmid to study the in vitro and in vivo biological effects on animal. The VRTIL-15 was entrapped with
chitosan modified with PEG-PEI (CS-PEG-PEI) to transfect HEK293 cells for the preliminary study of its expression in
eukaryotic cells. The total RNA of HEK293 cell was isolated in 48h, and the successful expression of IL-15 was detected by RT-
PCR and the supernatant of HEK293 cells was found to stimulate significant proliferation of lymphoblasts of pig. Subsequently,
VRTIL-15 packed with CS-PEG-PEI was utilized to intramuscularly inoculate Kunming female mice at the age of 21 days. Their
bloods were collected before and after inoculation on 1, 2, 3, 4 and 5 weeks to detect the changes of innate and adaptive
immunity of animals. The results were found that Th and Tc, specific antibody to FMD, IgG, IgG1, IgG2a content markedly
increased in the blood of treated mice compared with the control group (P<0.05). The mRNA expression of TLR1, TLR4 TLR6,
TLR9, TGF- , IL-2, IL-4, IL-6 and IL-23 were significantly higher in the treated group than those of the control (P<0.05).
These results indicate that the VRTIL-15 wrapped with CS-PEG-PEI can significantly improve the innate, humoral and cellular
adaptive immunity of animal, which could inspire the development of effective immune adjuvant to improve the comprehensive
immune protection of animals against FMD.
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1. Introduction
The Tibetan pig is the unique indigenous pig breed in China, and has evolved for nearly nine thousands of years
through natural selection in the Qinghai-Tibetan Plateau with an average altitude of more than 4200 m above sea
level. It become adapted to marginal feeding and harsh environment on the plateau and is well known for strong
resistance against various diseases and hypoxia environment1. But up to now little is known about the molecular
mechanisms for these unique performances, especially for its special immunity against diseases.
The interleukin-15 (IL-15) is an important cytokine in immune regulation of animal immune system, and has a
key role in the proliferation, survival and activation of CD8+ T, natural killer (NK) and other immune cells2,3,7.
Although its function is similar to IL-2, IL-15 utilizes different mechanisms of signaling with IL-15 receptors to
affect multitudinous target cells. Nowadays there is no report about IL-15 of Tibetan pig and far less than its role in
the immune responses to viral vaccination of animal. To further explore and clarify the immunogenetic
characteristics of Tibetan pig, here we conducted the present experiment to clone IL-15 gene of Tibetan pig and
analyze its potential as an immunoadjuvant to boost the immune responses to Foot and Mouth Disease(FMD)
vaccine which is still in urgent need of safe and effective adjuvant.
As a non-toxic, biocompatible and biodegradable polysaccharide, chitosan (CS) has attracted great attention in
recent years, and a number of applications in drug delivery have been found due to its favorable biological
properties4,5,16,18. In order to improve the efficiency of in vivo gene transfection in naimal, different chitosan
derivatives were prepared and employed to pack the recombinant expression plasmid for IL-15 gene in animal
vaccination experiment.
2. Materials and methods
2.1. TPIL-15 gene cloning and sequencing
Total RNA was extracted from the collected leukocytes of a Tibetan pig which was stimulated by LPS for 12
hours. RT-PCR is used for TPIL-15 gene cloning into pMD®19-Tvector (Takara), and then transformed into DH5α
competent cells. Primers were designed by Primer 5.0 with BamHI and BglII sites according to conserved ORF
sequence of IL-15 gene of Duroc pig, Landrace pig and other mammalians from NCBI/GenBank. PCR primers for
the IL-15 sequences are: TPIL-15-F: 5'ATGTGTTTGAGAAGTACTTG3', TPIL-15-
R:5'GTTCATCAACCCTTCTTGA3'. Plasmids were assessed for conformity by PCR and digested by BamHI and
BglII.Subsequently, the pMD®19-T/IL-15plasmids were sent toBGI biological company for sequencing. TPIL-
15sequence was aligned with domestic pigs and other mammalians by NCBI/Blast. Plasmid VR1020 is a eukaryotic
expression vector (Vical Company of America). We cloned the TPIL-15 into VR1020 to construct VTPIL-15 to get
secreted protein for in vitro and in vivo bioactivity test using the same fragment and methods as above mentioned.
2.2. Large-scale preparation of recombinant VTPIL-15, chitosan nanoparticles and characterization
A monoclonal cell line of recombinant DH5a E. coli, containing VTPIL-15or VR1020 plasmid, was inoculated in
LB broth with kanamycin (100 mg/ml) at 37200rpm overnight. Plasmid was extracted following the spermine
precipitation method described as Jason then the plasmid was resuspended in sterile water and stored at -20 until
use.
The VTPIL-15 plasmids were entrapped with chitosan (CS, provided by Chengdu Organic Chemistry Institute of
Chinese Academy of Science, China, MW: 50 kD and its deacetyl degree is over 95 percent) and its derivatives
(CS-PEG–PEI and CS-PEG-LAC, prepared in our lab as reported previously19,20 ) by ionotropic gelation method15,
16. The zeta potential and average diameter of the nanoparticles were characterized by Zeta-sizer 3000 HS/IHPL
(Malvern Instruments Ltd., Malvern, UK).
2.3. Gene transfection and bioactivity analysis
HEK293 cells were seeded in 12-well plates (1.0  105 cells/well) respectively. The cells were incubated in
Dulbecco’s modified Eagle medium (DMEM, Invitrogen Corporation.). The nanoparticles enwrapped with CS, CS-
PEG–PEI and CS-PEG-LAC containing 3 μg of DNA were added into the wells, respectively, then they were
incubated at 37in a 5% carbon dioxide humidified atmosphere.
The bioactivity of the TPIL-15 protein was measured by its ability to provoke the proliferation and cell viability
of pig lymphoblast stimulated with Concanavalin A (Con A) through CCK8 colorimetry. Lymphocyte Separation
Medium (LSM, ficoll 400) was used to separate pig peripheral blood mononuclear immune cells for in vitro
bioactivity test.
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2.4. Animal vaccination
Forty 4-week-old female Kunming mice (purchased from the Animal Center of West China Center of Medical
Sciences, Sichuan University) were randomly assigned to four groups (A1, A2, A3, C), 10 mice in each group. All
mice were muscularly injected with 0.2 ml inactivated FMD vaccine ( OZK93 +OS99 strain from Lanzhou
Veterinary Institute, China), 100μg the plasmids per mouse in the left and right quadriceps on day 0. Mice in group
A1 were injected with VTPIL-15/CS, A2 with VTPIL-15/CS-PEI-PEG, A3 with VTPIL-15/CS-PEI-LAC and group
C were injected with VR1020/CS as a negative control. Peripheral blood samples were collected from the tail vein
of mice on days 0, 7, 14, 21, 28 and 35 after immunization.
2.5 Bioactivity assay of TPIL-15 in vivo
2.5.1 Changes of immune cells in peripheral blood
Peripheral blood samples were used EDTA for anticoagulation, double diluted with normal saline, then analyzed
by blood testing instrument: MIND-RAY BC-3000 intelligent automatic blood cell analyzer. Blood test include red
blood cells, white blood cells, hemoglobin and platelet count and so on.
2.5.2 Assay of CD3, CD4 and CD8 positive T cells by FCM
Monoclonal antibody for FCM including Anti-Mouse CD3e FITC(0.5ug/Test), Anti-Mouse CD8a PE
(0.25ug/Test), and Anti-Mouse CD4 PerCP-Cy5.5(0.25ug/Test) for each Test contain 50μl peripheral blood
(monoclonal antibody were purchased from eBioscience Company, San Diego, USA.,). FACS Aria BD was used for
FCM analysis(BD Biosciences, USA).
2.5.3 Measurement of antibody, IgG, IgG1and IgG2a
Antibody to FMD, mouse IgG, IgG1, IgG2a measurement ELISA kits were respectively purchased from Keqian
Company of Wuhan, China and Bethyl Laboratory, Inc., America. The sandwich ELISA was conducted according
to the manufacturer’s protocols.
2.5.4 Analysis of immune gene mRNA expression
According to reports in GenBank, 10 pairs of specific primers for mouse β-actin, TRL1, TLR4, TLR6, TLR9,
TGF, IL-2, IL-4, IL-6 and IL-23 cDNA sequence were designed and synthesized (Table 1.).
Table1. The primers for real time q-PCR.
Genes primers5’-3’
β-actin-F TACGCCAACACGGTGCTGTC
β-actin-R GTACTCCTGCTTGCTGATCCACAT
TLR-1-F GGACCTACCCTTGCAAACAA
TLR-1-R GGTGGCACAAGATCACCTTT
TLR4-F ACCTGGCTGGTTTACACGTC
TLR-4-R CTGCCAGAGACATTGCAGAA
TLR-6-F CCAAGAACAAAAGCCCTGAG
TLR-6-R TGTTTTGCAACCGATTGTGT
TLR9-F ACTGAGCACCCCTGCTTCTA
TLR9-R AGATTAGTCAGCGGCAGGAA
TGF-β-F GGGAGTAGACAAGGTACAAC
TGF-β-R ACACACAGCCTCAGTT
IL-2-F AGCTCTGGAGGGAGTGCTAA
IL-2-R TGTTTCAGATCCCTTTAGTTCCA
IL-4F GCCATATCCACGGATGCGACAA
IL-4R GGTGTTCTTCGTTGCTGTGAGGA
IL-6F TCTTGGGACTGATGCTGGTGACA
IL-6R AGCCTCCGACTTGTGAAGTGGTAT
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IL-23-F TGCTGGATTGCAGAGCAGTAA
IL-23-R GCATGCAGAGATTCCGAGAGA
Quantitative real-time PCR (IQ5 Real Time PCR cycler, Bio-Rad) was performed to analyze the gene expression
of TRL1, TLR4, TLR6, TLR9, TGF-β, IL-2, IL-4, IL-6 and IL-23 and one reference genes , β-acting. In brief, 1 μL
of cDNA, primers, 5′-6-carboxyfluorescein (FAM) were added to a total of 25 μL in 1× TianGen™ QPCR Mix
(TianGen Peking, China).The relative expression of cytokine mRNA was calculated relative to the mean expression
of the cytokines or TLRs mRNA in the mice using the geometric means method and the formula: relative level =
2−ΔΔCt 22. Significant differences between the experimental groups were calculated for each gene using a Mann–
Whitney rank sum test on the relative cytokines/TLRs levels.
2.6 Statistical analysis
Data from all groups were presented as means ± SD, and statistical significance of the data was analyzed using
Student’s t-test. Differences betweenexperimental groups were considered to be significant when P-value was less
than 0.05.
3. Results
3.1 TPIL-15 gene cloning and sequencing
We successfully cloned TPIL-15 gene from the activated immune cells in blood. PCR products amplified
consistent with the expected size TPIL-15 gene-specific fragments. TPIL-15gene cDNA is 474 bp of encoding
sequence, and 158 amino acids. TPIL-15 cDNA,alignment with the NCBI pig IL-15 cDNA, have more than 99%
homology, and the cDNA sequence of TPIL-15 was submitted to GenBank, Sequence ID: gb|KF246518.1|
3.2 Size and potential of plasmids nanoparticles
The cationic nanoparticles had been considered as excellent candidates for gene transfection and expression in
cells. Under the transmission electron microscope, most of the nanoparticles were spherical and the average granule
diameter was 210 nm (range from 181 to 276 nm) analyzed by Zetasizer 3000 HS/IHPL, the diversity of chitosan
nanoparticles was 0.167, zeta potential was 40.57mV revealed in
Table 2. The nanoparticles package of recombinant plasmids
Sample T () w/w
size (d.nm) Zeta Potential (mV)
Average SD(±) Average SD(±)
CS/DNA 25 301 222.2 5.15 +40.57 1.6
CS-PEG-PEI/DNA 25 101 181.2 11.72 +41.9 2.13
CS-PEG-LAC/DNA 25 101 276.83 9.28 +39.23 1.78
3.3 Proliferation of pig lymphoblasts in vitro
Firstly, we got TPIL-15 protein by transfection of HEK293 cell with the packed recombinant TPIL-15 plasmids
in vitro, the transfection and gene expression efficiency were confirmed by reverse transcription PCR (RT-PCR).
Bioactivity of TPIL-15 protein was detected by CCK-8. After using different nanoparticles to transfect HEK293
cells for 12h, 24h, 48h and 72h, supernatants of cell culture were used to stimulate the proliferation of pig
lymphoblasts, and the results showed that the proliferation of pig lymphoblasts were increased by the CS
derivatives (CS-PEG–PEI and CS-PEG-LAC) nanoparticles compared with control groups (Figure1), indicating
that the molecular package with chitosan derivatives could promote the expression of TPIL-15 protein (P <0.05).
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Figure 1. Lymphocytes proliferation of different supernatants of package molecules. A: chitosan (CS); B: poly
(ethylene glycol) (PEI); C: CS-PEG-Lac; D: CS-PEI-PEG;
3.4 Immune responses of the mice in vivo
3.4.1 Immune cells in the peripheral blood of mice
During 35days postinoculation, the growth rate of the experimental mice was significantly higher than control
group (P<0.05), but after 21 days, the growth rates gradually slowed. There are no significant differences among CS,
CS-PEG–PEI and CS-PEG-LAC treated groups (P>0.05) (Figure 2. a). As shown in Figure 2 b, c leukocytes and
erythrocytes significantly increased in the experimental mice in comparison with the control group (P <0.05).
a b
Figure 2. Changes of weight and immune cells in the
peripheral blood of mice.
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3.4.2 CD4+ and CD8+ T cells
20,000 leukocytes were randomly selected to count CD4+ and CD8+T lymphocyte by FCM. The percentage and
absolute value of CD4+ and CD8+T lymphocyte were both significantly increased in the peripheral blood of the
treated mice in comparison with those of the control mice from 21 to 35days (P <0.05); CD4+/ CD8+ ratio
remained relatively stable (approximate2-2.5 folds) (P> 0.05) during the observation period(Figure 3. a, b).
a b
Figure 3. Changes of CD4+ and CD8+ T cells in the peripheral blood of experimental mice.
3.4.3 Antibody and immunoglobulins
Figure 2.4.3 showed that the specific FMD antibody, IgG, IgG1and IgG2a levels in the sera of the treated mice
significantly increased than the control group (P<0.05). The ratio of IgG1/IgG2a maintained at about 1.4.This shows
that the mice were more likely to induce humoral immune response. CS, CS-PEG–PEI and CS-PEG-LAC package
nanoparticle did not elicited significant differences among the treated groups (P>0.05)(Figure 4. a-d).
a b
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c d
Figure 4. Changes of antibody and immunoglobulins in the peripheral blood of experimental mice.
3.4.4 Toll like receptors genes expression
Standard curve correlation co-efficient ofTLRs primers testing were above 0.99, PCR amplification efficiency
was 95%-105%. The results show that there were effective linear relationships PCR between the samples.TLRs
were increased significantly during 0-35 days as showed in Figure 5 (P<0.05). TLR4 and TLR9 mRNA increased
significantly more than other TLRs from 0-21days. But TLR6 shows more cascade effect which elevated six times
than the level before inoculation, and CS-PEG-PEI induced significantly higher responses than other materials
(Figure 5. a-d).
a b
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c d
Figure 5. Changes of TLRs gene expression in the immune cells from peripheral blood of experimental mice.
3.4.5. Interleukins and TGF-β gene expression
Standard curve correlation co-efficient of interleukins and TGF-β primers testing were above 0.99, PCR
amplification efficiency were 95%-105%. Transcription levels of IL-2, IL-4, IL-6 and IL-23 were significantly
increased in the treated mice compared to those of the control mice during 35 days period (P <0.05) (Figure 6. a-e).
a b
88   Xiaoping Wan et al. /  Procedia in Vaccinology  9 ( 2015 )  80 – 90 
c d
e
Figure 6. Changes of TGF-β and interleukin gene expression in the immune cells from the peripheral blood of
experimental mice.
4. Discussion
The cationic polymers as CS, modified-CS and PEI have been considered as excellent candidates for preparation
of nanoparticles15,18. Nanoparticles with specific size and positive charge on surface are necessary for endocytosis.
Researches showed that many of proteins, drugs and DNA complexes were sensitive to bonding with cationic
biomaterials delivery system; therefore, multi-cationic PEI was introduced onto CS to enhance the positive charge of
the nanoparticles19,20. In our work, the average diameter of CS-PEG-PEI was smaller than packaged with CS which
probably due to the increase of DNA binding/condensation capability. The zeta potential of CS-PEG-PEI was in the
positive range and was higher than that of CS due to the introduction of polymeric PEI. As expected, with the
increase of the mass ratio, the average diameter became smaller and smaller, and the zeta potential turned to be more
positive, which suggest its better effectiveness for transfection and delivery of plasmids into cells.
In vivo experiment, CS-PEG-PEI/CS-PEG-LAC groups compared with CS/VR1020 group showed higher
transfection efficency. Moreover, CS-PEG-PEI/CS-PEG-LAC nanoparticles were far less cytotoxic than PEI(data in
our lab). There were also no detectable side effects in the weight gain, peripheral blood and the injection site of
immunized mice.
It is recognized that IL-15/IL-15R signaling could modulate multiple functions of different immunocompetent
cells, including T and B lymphocytes, NK cells, neutrophils and monocytes/macrophages of animals. IL-15/IL-
15R is necessary for T lymphocyte development and homeostasis, and memory CD8+ T-cell and NK cell
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development, maintenance, expansion and activities2,3,5,8. Therefore, it was consistent with our findings that
CD+4/CD8+ T cell both increased in the peripheral blood of mice treated with packed VTPIL-15 nanoparticles.
Similarly, IL-15/IL-15R signaling affects B lymphocytes by activation of Syk kinase and PLCγ, protection from
apoptosis, induction of proliferation and differentiation, and Ig production4,6,13. Hence the results were found that the
specific antibody to FMD vaccine and the IgG significantly increased in the sera of mice injected with IL-15
nanoparticles.
IL-15/IL-15R signaling can also remarkably elicit the activation of Jak2, Syk, p38, ERK1/2, NF-kB and down
regulation of Bax, increase Mcl-1 protection from apoptosis, promote phagocytosis of mast cells, neutrophis and
macrophages, which in turn enhance the phagocytosis for pathogen clearance and production of MCP-1,
superoxide and interleukins5,6,14 . These changes could further increase expression of CD86, CD40 and MHC II in
the immune cells that would amplify the relevant cellular and humoral immune responses8, 9, 12. Besides, IL-15 can
exert stimulatory effects on mast cells and dendritic cells by activation of STAT3, Jak2/STAT5,Tyk2/STAT6 and
Syk, induce higher expression of Bcl-xL and c-Myc that lead to inhibition of apoptosis and support their
proliferation and secretion of cytokines10, 11,17.
Based on our results, it is clear that the expressions of TRL1, TLR4, TLR6 and TLR9 genes were significantly
increased by injection of recombinant IL-15 gene nanoparticles, which is closely associated with marked activation
of non-specific immune cells, including monocytes /macrophages. TLR9 can specifically identify CpG-DNA
sequence from bacteria and viruses.In additions, TLR9 can promote the ability of APC antigen-presenting to induce
a variety of pro-inflammatory cytokines to speed up the defense reaction against infection of pathogens.
Interestingly, our results firstly reported that the expression of TGF-β and IL-23 genes were enhanced from 7
to 35 days after TPIL-15 nanoparticles injection; These prove that the entrapment of TPIL-15gene with chitosan and
its derivatives is effective for gene delivery and transfection to elevate the innate and adaptive immunity of animals
against pathogen. IL-23 is one of the critical cytokines for proliferation and development of immune memory cells
(BM/TM) 21, it has a positive correlation with protective immunity. Therefore, TPIL-15 would not only potentiate
immune responses of inoculated animals, but also facilitate the development of stronger immune memory capacity
to prolong putative immnuoprotection of vaccinated animals against reinfection.
In a word, TPIL-15 genes enwrapped with CS-PEG-PEI/CS-PEG-LAC is a promising and effective novel
immunoadjuvant to improve the comprehensive immunity of animals to vaccine, which is worth of further
exploration for preparation of safe and practicable molecular adjuvant.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (No.30871855), National
International Cooperation Program (No.2011DFA10101103) and a breeding project from Sichuan Province of China.
We sincerely thank Dr. Gang Wang (National Engineering Research Center for Biomaterials) for technical support.
References
1. Li M., Wu H, Luo Z, et al. An atlas of DNA methylomes in porcine adipose and muscle tissues. Nat Commun 2012; 3, 850.
2. Tan JT. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for
memory phenotype CD4+ cells. Journal of Experimental Medicine 2002; 195(12):1523-1532.
3. Bazan JF. Haemopoietic receptors and helical cytokines. Immunology Today 1990; 11: 350-354.
4. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH. IL-15 has stimulatory activity for the induction of B cell proliferation and
differentiation. The Journal of Immunology 1995; 54: 483-490.
5. Budagian V, Bulanova E, Paus R, Bulfone-Paus S. IL-15/IL-15 receptor biology: A guided tour through an expanding universe. Cytokine &
Growth Factor Reviews 2006;17: 259-280.
6. Bulanova E, Budagian V, Pohl T, Krause H, Dürkop H, et al. The IL-15Rα Chain Signals Through Association with Syk in Human B Cells.
The Journal of Immunology 2001; 167: 6292-6302.
7. Fehniger TA, Cooper MA, Caligiuri MA. Interleukin-2 and interleukin-15: immunotherapy for cancer. Cytokine & Growth Factor Reviews
2002; 13: 169-183.
8. Lodolce J, Burkett P, Koka R, Boone D, Chien M, et al. Interleukin-15 and the regulation of lymphoid homeostasis. Molecular Immunology
2002;39: 537-544.
9. Ratthé C, Girard D. Interleukin-15 enhances human neutrophil phagocytosis by a Syk-dependent mechanism: importance of the IL-15Rα
chain. Journal of Leukocyte Biology 2004; 76: 162-168.
90   Xiaoping Wan et al. /  Procedia in Vaccinology  9 ( 2015 )  80 – 90 
10. Masuda A, Matsuguchi T, Yamaki K, Hayakawa T, Kubo M, et al. Interleukin-15 Induces Rapid Tyrosine Phosphorylation of STAT6 and
the Expression of Interleukin-4 in Mouse Mast Cells. Journal of Biological Chemistry 2000; 275: 29331-29337.
11. Masuda A, Matsuguchi T, Yamaki K, Hayakawa T, Yoshikai Y. Interleukin-15 Prevents Mouse Mast Cell Apoptosis through STAT6-
mediated Bcl-xL Expression. Journal of Biological Chemistry 2001; 276: 26107-26113.
12. Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, et al. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med 1997; 3:
1124-1128.
13. Trentin L, Zambello R, Facco M, Sancetta R, Agostini C, et al.Interleukin-15: A Novel Cytokine with Regulatory Properties on Normal and
Neoplastic B Lymphocytes. Leukemia & Lymphoma 1997; 27: 35-42.
14. Bulanova E, Budagian V, Orinska Z, Krause H, Paus R, et al. Mast Cells Express Novel Functional IL-15 Receptor α Isoforms. The Journal
of Immunology 2003; 170: 5045-5055.
15. Bodmeier R, Chen HG, Paeratakul O. A novel approach to the oral delivery of micro- or nanoparticles. Pharm Res 1989; 6: 413-417.
16. Yang X, Xiao Y-L, Chen J-L, Chen C, Zhang H, et al. Potentiation of Immunity of Piglets to Mycoplasma Hyopneumoniae Vaccine with
Fused Gene for Pig IL-4 and IL-6 Embodied in Chitosan Nanoparticles. Procedia in Vaccinology 2013; 7: 15-22.
17. Lodolce JP, Burkett PR, Koka RM, Boone DL, Ma A Regulation of lymphoid homeostasis by interleukin-15. Cytokine & Growth Factor
Reviews 2002; 13: 429-439.
18. Xie Z, Li H, Chen J, Zhang H-b, Wang Y-Y, et al. Shuffling of pig interleukin-2 gene and its enhancing of immunity in mice to Pasteurella
multocida vaccine. Vaccine 2007; 25: 8163-8171.
19. Yu YY, Wang Z, Cai L, Wang G, Yang X, et al. Synthesis and characterization of methoxy poly(ethylene glycol)-O-chitosan-
polyethylenimine for gene delivery. Carbohydrate Polymers 2010;81: 269-274.
20. Xu Z, Wan X, Zhang W, Wang Z, Peng R, et al.Synthesis of biodegradable polycationic methoxy poly(ethylene glycol)–polyethylenimine–
chitosan and its potential as gene carrier. Carbohydrate Polymers 2009; 78: 46-53.
21. Tan ZY, Bealgey KW, Fang Y, Gong YM, et al. Interleukin-23: Immunological roles and clinical implications,The International Journal of
Biochemistry & Cell Biology 2009; 41: 733–735
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 2001;
25(4):402-408.
